Selegiline Is Ineffective in a Collaborative Double-blind, Placebo-Controlled Trial for Treatment of Amyotrophic Lateral Sclerosis

Abstract

Selegiline treatment had no significant effect on the rate of clinical progression or outcome of ALS.